文献速递产科母胎医学

绒毛膜绒毛取样和羊膜腔穿刺术后的操作相关流产风险

Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2019-09-06

该回顾性队列研究纳入2009年1月至2018年5月英国一家胎儿医学中心的43,691例单胎妊娠,其中861例接受绒毛膜绒毛取样(CVS)、375例接受羊膜腔穿刺术。CVS组流产风险为1.5%(13/861),未手术组为1.2%(476/39,152),P=0.437;羊膜腔穿刺组为0.8%(3/375),未手术组为1.2%(491/42,463),P=0.520,操作相关风险差异均无统计学意义。

要点

  • CVS组流产风险1.5%(13/861),未手术组1.2%(476/39,152),P=0.437。
  • 羊膜腔穿刺组流产风险0.8%(3/375),未手术组1.2%(491/42,463),P=0.520。
  • CVS操作相关风险0.29%(95%CI -0.53至1.12%),羊膜腔穿刺为-0.36%(95%CI -1.26至0.55%)。

核心结论

  • 本研究中CVS和羊膜腔穿刺后的操作相关流产风险显著低于目前引用的数值,与系统综述和荟萃分析的估计一致。

研究设计与样本

  • 回顾性队列研究,数据来自英国一家大型胎儿医学中心2009年1月至2018年5月。
  • 纳入20周前在该中心建档的单胎妊娠,排除多胎、严重胎儿缺陷、终止妊娠和失访者。
  • 最终分析43,691例单胎妊娠,其中861例接受CVS,375例接受羊膜腔穿刺术。

主要发现

  • CVS组流产风险1.5%(13/861),未手术组1.2%(476/39,152),P=0.437。
  • 羊膜腔穿刺组流产风险0.8%(3/375),未手术组1.2%(491/42,463),P=0.520。
  • 单因素和多因素回归分析显示CVS对流产风险无显著贡献(P=0.399和P=0.592)。
  • 羊膜腔穿刺对流产风险无显著贡献(P=0.543和P=0.550)。
  • CVS操作相关风险0.29%(95%CI -0.53至1.12%),羊膜腔穿刺为-0.36%(95%CI -1.26至0.55%),与未手术组无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To estimate the procedure-related risks of miscarriage following chorionic villus sampling (CVS) and amniocentesis in a large unselected screened population, and to determine whether these risks are consistent with those reported in systematic reviews and meta-analyses. METHODS: This was a retrospective cohort study carried out on data obtained from a large fetal medicine unit in the UK between January 2009 and May 2018. We included all women with singleton pregnancy who booked for pregnancy care at our unit before 20 weeks' gestation, after excluding those with multiple pregnancy, major fetal defect, pregnancy termination and loss to follow-up. We estimated the risk of miscarriage in women who underwent a CVS or amniocentesis as well as in those who did not have an invasive procedure. The procedure-related risk of miscarriage was estimated as risk difference (95% CI) between the two groups. Univariate and multivariate regression analyses were used to derive odds ratios (95% CI) and determine which maternal and pregnancy characteristics provided a significant contribution in the prediction of miscarriage and whether CVS or amniocentesis provided a significant independent contribution. RESULTS: During the study period, 45 120 singleton pregnancies were booked for pregnancy care at our hospital, of which 1546 had an invasive procedure. We excluded 1429 (3.2%) pregnancies due to fetal defects, termination of pregnancy or missing outcomes. Of the 43 691 pregnancies included in the study population, 861 underwent CVS and 375 amniocentesis. In pregnancies that underwent CVS, the risk of miscarriage was 1.5% (13/861), compared with 1.2% (476/39 152) in pregnancies that had first-trimester combined screening and did not have an invasive procedure (P = 0.437). In pregnancies that underwent an amniocentesis, the risk of miscarriage was 0.8% (3/375), compared with 1.2% (491/42 463) in those that did not undergo an invasive procedure (P = 0.520). Univariate and multivariate regression analysis demonstrated that there was no significant contribution in the prediction of the risk of miscarriage from CVS (P = 0.399 and P = 0.592, respectively) or amniocentesis (P = 0.543 and P = 0.550, respectively). The risk of procedure-related loss attributed to CVS was 0.29% (95% CI, -0.53 to 1.12%) and that following amniocentesis was -0.36% (95% CI, -1.26 to 0.55%), which was not significantly different from the risk in women who did not have any procedure. CONCLUSIONS: The procedure-related risks of miscarriage following CVS and amniocentesis in our study are considerably lower than those currently quoted and are consistent with the estimates of such risks reported by systematic reviews and meta-analyses. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Beta J, Zhang W, Geris S, et al. Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis. Ultrasound Obstet Gynecol. 2019. PMID: 30977213. doi:10.1002/uog.20293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。